Matches in Nanopublications for { ?s ?p "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_assertion description "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_provenance.
- NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_assertion description "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_provenance.
- NP1204904.RAA4Ljq08AiCMvIooWDlNuqKpg7cOoQ5iHWQQSBiSBEqs130_assertion description "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1204904.RAA4Ljq08AiCMvIooWDlNuqKpg7cOoQ5iHWQQSBiSBEqs130_provenance.
- NP622561.RAohYL6VSAhl3qRQ7dBuwy_Wv-HVXuGddFSzZ7F_LcJw0130_assertion description "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622561.RAohYL6VSAhl3qRQ7dBuwy_Wv-HVXuGddFSzZ7F_LcJw0130_provenance.
- NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_assertion description "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_provenance.
- NP1204901.RAne3aTlmSHc8VfFi4kE-k08ahmAR3XG0oSfJL7BuVOi8130_assertion description "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1204901.RAne3aTlmSHc8VfFi4kE-k08ahmAR3XG0oSfJL7BuVOi8130_provenance.
- NP1204903.RA6iygQGMWbtCefvBvpCqBYZMo30lG0oC5zfLo7bHs8fI130_assertion description "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1204903.RA6iygQGMWbtCefvBvpCqBYZMo30lG0oC5zfLo7bHs8fI130_provenance.
- NP1204907.RA2fRnjrkrlLF_UjNjw_XLdwfwQ67KiirUeJaE66HZ5Bc130_assertion description "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1204907.RA2fRnjrkrlLF_UjNjw_XLdwfwQ67KiirUeJaE66HZ5Bc130_provenance.